Skip to main content
Top
Published in: Lung 4/2014

01-08-2014

Diaphragmatic Motion Studied by M-mode Ultrasonography in Combined Pulmonary Fibrosis and Emphysema

Authors: Li He, Wanguang Zhang, Jiahong Zhang, Le Cao, Lan Gong, Jingping Ma, He Huang, Jinwu Zeng, Chuanbin Zhu, Jianhua Gong, Yongjian Xu, Zhenxiang Zhang, Jianping Zhao, Huilan Zhang

Published in: Lung | Issue 4/2014

Login to get access

Abstract

Background

The coexistence of emphysema and pulmonary fibrosis is known as combined pulmonary fibrosis and emphysema (CPFE). The aim of this study was to compare diaphragmatic motion measured by M-mode ultrasonography of patients with CPFE, idiopathic pulmonary fibrosis (IPF), and chronic obstructive pulmonary disease (COPD).

Methods

Pulmonary function, high-resolution computed tomography (HRCT), and diaphragmatic motion were examined in patients with CPFE (n = 25), IPF (n = 18), and COPD (n = 60), and in healthy controls (n = 21). Diaphragmatic motions were measured on M-mode ultrasonographic images during quiet breathing and deep breathing.

Results

There were no significant differences in right or left diaphragmatic motion during quiet breathing among the four groups, whereas differences were significant in right and left motion during deep breathing. Diaphragmatic motion in CPFE patients was the lowest among the four groups. COPD patients, especially those with severe COPD, showed significantly lower diaphragmatic motion than IPF patients or healthy controls. There were no differences in diaphragmatic motion between IPF patients and healthy controls. Right diaphragmatic motions during deep breathing were negatively correlated with emphysema scores (r = −0.606, p < 0.001), but were not correlated with fibrosis scores on HRCT.

Conclusions

Diaphragmatic weakness was found in CPFE patients. Emphysema but not fibrosis may be one cause of limited diaphragmatic motion in patients with CPFE. M-mode ultrasonographic evaluation of diaphragmatic motion during deep breathing may be a useful tool in diagnosing CPFE and in discriminating CPFE patients from IPF or COPD patients.
Literature
2.
go back to reference Glerant JC, Mustfa N, Man WD, Luo YM, Rafferty G, Polkey MI, Moxham J (2006) Diaphragm electromyograms recorded from multiple surface electrodes following magnetic stimulation. Eur Respir J 27(2):334–342CrossRefPubMed Glerant JC, Mustfa N, Man WD, Luo YM, Rafferty G, Polkey MI, Moxham J (2006) Diaphragm electromyograms recorded from multiple surface electrodes following magnetic stimulation. Eur Respir J 27(2):334–342CrossRefPubMed
3.
go back to reference Mageras GS, Yorke E, Rosenzweig K, Braban L, Keatley E, Ford E, Leibel SA, Ling CC (2001) Fluoroscopic evaluation of diaphragmatic motion reduction with a respiratory gated radiotherapy system. J Appl Clin Med Phys 2(4):191–200CrossRefPubMed Mageras GS, Yorke E, Rosenzweig K, Braban L, Keatley E, Ford E, Leibel SA, Ling CC (2001) Fluoroscopic evaluation of diaphragmatic motion reduction with a respiratory gated radiotherapy system. J Appl Clin Med Phys 2(4):191–200CrossRefPubMed
5.
go back to reference Paulin E, Yamaguti WP, Chammas MC, Shibao S, Stelmach R, Cukier A, Carvalho CR (2007) Influence of diaphragmatic mobility on exercise tolerance and dyspnea in patients with COPD. Respir Med 101(10):2113–2118CrossRefPubMed Paulin E, Yamaguti WP, Chammas MC, Shibao S, Stelmach R, Cukier A, Carvalho CR (2007) Influence of diaphragmatic mobility on exercise tolerance and dyspnea in patients with COPD. Respir Med 101(10):2113–2118CrossRefPubMed
6.
go back to reference Papiris SA, Triantafillidou C, Manali ED, Kolilekas L, Baou K, Kagouridis K, Bouros D (2013) Combined pulmonary fibrosis and emphysema. Expert Rev Respir Med 7(1):19–31; quiz 32. doi:10.1586/ers.12.80 Papiris SA, Triantafillidou C, Manali ED, Kolilekas L, Baou K, Kagouridis K, Bouros D (2013) Combined pulmonary fibrosis and emphysema. Expert Rev Respir Med 7(1):19–31; quiz 32. doi:10.​1586/​ers.​12.​80
7.
go back to reference Qaseem A, Wilt TJ, Weinberger SE et al (2011) Diagnosis and management of stable chronic obstructive pulmonary disease: a clinical practice guideline update from the American College of Physicians, American College of Chest Physicians, American Thoracic Society, and European Respiratory Society. Ann Intern Med 155(3):179–191. doi:10.7326/0003-4819-155-3-201108020-00008 CrossRefPubMed Qaseem A, Wilt TJ, Weinberger SE et al (2011) Diagnosis and management of stable chronic obstructive pulmonary disease: a clinical practice guideline update from the American College of Physicians, American College of Chest Physicians, American Thoracic Society, and European Respiratory Society. Ann Intern Med 155(3):179–191. doi:10.​7326/​0003-4819-155-3-201108020-00008 CrossRefPubMed
8.
go back to reference Raghu G, Collard HR, Egan JJ et al (2011) ATS/ERS/JRS/ALAT Committee on Idiopathic Pulmonary Fibrosis. An official ATS/ERS/JRS/ALAT statement: idiopathic pulmonary fibrosis: evidence-based guidelines for diagnosis and management. Am J Respir Crit Care Med 15;183(6):788–824. doi:10.1164/rccm Raghu G, Collard HR, Egan JJ et al (2011) ATS/ERS/JRS/ALAT Committee on Idiopathic Pulmonary Fibrosis. An official ATS/ERS/JRS/ALAT statement: idiopathic pulmonary fibrosis: evidence-based guidelines for diagnosis and management. Am J Respir Crit Care Med 15;183(6):788–824. doi:10.​1164/​rccm
9.
go back to reference Miller MR, Hankinson J, Brusasco V et al (2005) ATS/ERS Task Force. Standardisation of spirometry. Eur Respir J 26(2):319–338CrossRefPubMed Miller MR, Hankinson J, Brusasco V et al (2005) ATS/ERS Task Force. Standardisation of spirometry. Eur Respir J 26(2):319–338CrossRefPubMed
10.
go back to reference Ginghină C, Muraru D, Vlădaia A et al (2009) Doppler flow patterns in the evaluation of pulmonary hypertension. Rom J Intern Med 47(2):109–121PubMed Ginghină C, Muraru D, Vlădaia A et al (2009) Doppler flow patterns in the evaluation of pulmonary hypertension. Rom J Intern Med 47(2):109–121PubMed
11.
go back to reference Mori K, Shirai T, Mikamo M, Shishido Y, Akita T, Morita S, Asada K, Fujii M, Hozumi H, Suda T, Chida K (2013) Respiratory mechanics measured by forced oscillation technique in combined pulmonary fibrosis and emphysema. Respir Physiol Neurobiol 185(2):235–240. doi:10.1016/j.resp.2012.10.009 CrossRefPubMed Mori K, Shirai T, Mikamo M, Shishido Y, Akita T, Morita S, Asada K, Fujii M, Hozumi H, Suda T, Chida K (2013) Respiratory mechanics measured by forced oscillation technique in combined pulmonary fibrosis and emphysema. Respir Physiol Neurobiol 185(2):235–240. doi:10.​1016/​j.​resp.​2012.​10.​009 CrossRefPubMed
12.
go back to reference Hozumi H, Nakamura Y, Johkoh T, Sumikawa H, Colby TV, Karayama M, Hayakawa H, Yokomura K, Imokawa S, Yasuda K, Toyoshima M, Suganuma H, Shirai T, Inui N, Suda T, Nakamura H, Chida K (2011) Nonspecific interstitial pneumonia: prognostic significance of high-resolution computed tomography in 59 patients. J Comput Assist Tomogr 35(5):583–589. doi:10.1097/RCT.0b013e31822a5883 CrossRefPubMed Hozumi H, Nakamura Y, Johkoh T, Sumikawa H, Colby TV, Karayama M, Hayakawa H, Yokomura K, Imokawa S, Yasuda K, Toyoshima M, Suganuma H, Shirai T, Inui N, Suda T, Nakamura H, Chida K (2011) Nonspecific interstitial pneumonia: prognostic significance of high-resolution computed tomography in 59 patients. J Comput Assist Tomogr 35(5):583–589. doi:10.​1097/​RCT.​0b013e31822a5883​ CrossRefPubMed
14.
go back to reference Kantarci F, Mihmanli I, Demirel MK, Harmanci K, Akman C, Aydogan F, Mihmanli A, Uysal O (2004) Normal diaphragmatic motion and the effects of body composition: determination with M-mode sonography. J Ultrasound Med 23(2):255–260PubMed Kantarci F, Mihmanli I, Demirel MK, Harmanci K, Akman C, Aydogan F, Mihmanli A, Uysal O (2004) Normal diaphragmatic motion and the effects of body composition: determination with M-mode sonography. J Ultrasound Med 23(2):255–260PubMed
16.
go back to reference Brennan NJ, Morris AJ, Green M (1983) Thoracoabdominal mechanics during tidal breathing in normal subjects and in emphysema and fibrosing alveolitis. Thorax 38(1):62–66PubMedCentralCrossRefPubMed Brennan NJ, Morris AJ, Green M (1983) Thoracoabdominal mechanics during tidal breathing in normal subjects and in emphysema and fibrosing alveolitis. Thorax 38(1):62–66PubMedCentralCrossRefPubMed
17.
go back to reference Green M, Mead J, Sears TA (1978) Muscle activity during chest wall restriction and positive pressure breathing in man. Respir Physiol 35(3):283–300CrossRefPubMed Green M, Mead J, Sears TA (1978) Muscle activity during chest wall restriction and positive pressure breathing in man. Respir Physiol 35(3):283–300CrossRefPubMed
19.
go back to reference Kawamoto H, Kambe M, Kuraoka T (2008) Evaluation of the diaphragm in patients with COPD (emphysema dominant type) by abdominal ultrasonography. Nihon Kokyuki Gakkai Zasshi 46(4):271–277PubMed Kawamoto H, Kambe M, Kuraoka T (2008) Evaluation of the diaphragm in patients with COPD (emphysema dominant type) by abdominal ultrasonography. Nihon Kokyuki Gakkai Zasshi 46(4):271–277PubMed
23.
go back to reference Ponçot-Mongars R, Zysman M, Regent D, Gomez E, Chaouat A, Chabot F (2013) Combined pulmonary fibrosis and emphysema: the natural history of the disease. The chronological evolution of clinical features, respiratory function and the CT scan. Rev Mal Respir 30(3):222–226. doi:10.1016/j.rmr.2012.06.002 CrossRefPubMed Ponçot-Mongars R, Zysman M, Regent D, Gomez E, Chaouat A, Chabot F (2013) Combined pulmonary fibrosis and emphysema: the natural history of the disease. The chronological evolution of clinical features, respiratory function and the CT scan. Rev Mal Respir 30(3):222–226. doi:10.​1016/​j.​rmr.​2012.​06.​002 CrossRefPubMed
25.
go back to reference Cottin V, Nunes H, Brillet PY et al (2005) Combined pulmonary fibrosis and emphysema: a distinct underrecognised entity. Eur Respir J 26(4):586–593CrossRefPubMed Cottin V, Nunes H, Brillet PY et al (2005) Combined pulmonary fibrosis and emphysema: a distinct underrecognised entity. Eur Respir J 26(4):586–593CrossRefPubMed
26.
go back to reference de Man FS, van Hees HW, Handoko ML, Niessen HW, Schalij I, Humbert M, Dorfmüller P, Mercier O, Bogaard HJ, Postmus PE, Westerhof N, Stienen GJ, van der Laarse WJ, Vonk-Noordegraaf A, Ottenheijm CA (2011) Diaphragm muscle fiber weakness in pulmonary hypertension. Am J Respir Crit Care Med 183(10):1411–1418. doi:10.1164/rccm.201003-0354OC CrossRefPubMed de Man FS, van Hees HW, Handoko ML, Niessen HW, Schalij I, Humbert M, Dorfmüller P, Mercier O, Bogaard HJ, Postmus PE, Westerhof N, Stienen GJ, van der Laarse WJ, Vonk-Noordegraaf A, Ottenheijm CA (2011) Diaphragm muscle fiber weakness in pulmonary hypertension. Am J Respir Crit Care Med 183(10):1411–1418. doi:10.​1164/​rccm.​201003-0354OC CrossRefPubMed
28.
go back to reference Manders E, de Man FS, Handoko ML, Westerhof N, van Hees HW, Stienen GJ, Vonk-Noordegraaf A, Ottenheijm CA (2012) Diaphragm weakness in pulmonary arterial hypertension: role of sarcomeric dysfunction. Am J Physiol Lung Cell Mol Physiol 303(12):L1070–L1078. doi:10.1152/ajplung.00135.2012 CrossRefPubMed Manders E, de Man FS, Handoko ML, Westerhof N, van Hees HW, Stienen GJ, Vonk-Noordegraaf A, Ottenheijm CA (2012) Diaphragm weakness in pulmonary arterial hypertension: role of sarcomeric dysfunction. Am J Physiol Lung Cell Mol Physiol 303(12):L1070–L1078. doi:10.​1152/​ajplung.​00135.​2012 CrossRefPubMed
Metadata
Title
Diaphragmatic Motion Studied by M-mode Ultrasonography in Combined Pulmonary Fibrosis and Emphysema
Authors
Li He
Wanguang Zhang
Jiahong Zhang
Le Cao
Lan Gong
Jingping Ma
He Huang
Jinwu Zeng
Chuanbin Zhu
Jianhua Gong
Yongjian Xu
Zhenxiang Zhang
Jianping Zhao
Huilan Zhang
Publication date
01-08-2014
Publisher
Springer US
Published in
Lung / Issue 4/2014
Print ISSN: 0341-2040
Electronic ISSN: 1432-1750
DOI
https://doi.org/10.1007/s00408-014-9594-5

Other articles of this Issue 4/2014

Lung 4/2014 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine